ZeClinics is a Biotech Contract Research Organization (CRO) and early-phase biopharmaceutical (PHARMA) company using zebrafish (Danio rerio) for safety and efficacy screenings of novel chemical molecules.
We are supported by the University Pompeu Fabra (UPF) and allowed to grow within the exciting environment of the Barcelona Biomedicine Research Park (PRBB). Our business strengths rely on high technical expertise and top-notch research facilities, combined with attractive strategic partnerships and academic collaborations.
We aim to challenge the traditional drug discovery pipeline by offering a cheap, fast and reliable array of customized assays, to assess the safety and biomedical relevance of novel molecules using zebrafish.
In a challenging economic environment ZeClinics represents a fine example of a business model that uses research and innovation as a way to success.